UK government finally concedes cannabis has a medicinal effect
Exclusive: The MHRA's assessment could 'provide ground-breaking results' in leading to reform over cannabis' medicinal use in the UK
Your support helps us to tell the story
This election is still a dead heat, according to most polls. In a fight with such wafer-thin margins, we need reporters on the ground talking to the people Trump and Harris are courting. Your support allows us to keep sending journalists to the story.
The Independent is trusted by 27 million Americans from across the entire political spectrum every month. Unlike many other quality news outlets, we choose not to lock you out of our reporting and analysis with paywalls. But quality journalism must still be paid for.
Help us keep bring these critical stories to light. Your support makes all the difference.
The government’s Medicines and Healthcare products Regulatory Agency (MHRA) has found that Cannabidiol (CBD) has a “restoring, correcting or modifying” effect on “physiological functions” when administered to humans, in a potential milestone in the campaign to legalise cannabis and bring about evidence-based laws regarding drugs.
The review of CBD, a cannabinoid accounting for up to 40% of the marijuana plant's extract that doesn't contain its psychoactive THC but is purported to retain the health benefits, came about following discussions with CBD vaporiser company MediPen.
The MHRA’s findings are not directly applicable to the government’s response to last year’s petition to legalise cannabis, but stand in stark contrast, with the petition having been batted away by the Home Office with the assessment that cannabis “can unquestionably cause harm to individuals and society”.
GW Pharmaceuticals has also just concluded a positive phase 3 clinical trial demonstrating the safety and efficacy of CBD, which has helped people with a variety of illnesses.
“Since our inception we’ve worked hard to obtain our goal of breaking down the negative connotations surrounding Cannabis to lead to a reform in the law for medicinal use,” Jordan Owen, Managing Director of MediPen, told The Independent, “now this is finally becoming a reality, which will provide ground-breaking results.”
The company was moved to contact the MHRA after its legal team pointed out there was originally no regulatory status for CBD, allowing the industry in the UK to flourish without any premature intervention. Following the review, CBD vendors will soon need a licence to sell their products or face a fine or two-year prison sentence.
"If you use CBD and if you have any questions, speak to your GP or other healthcare professional," an MHRA spokesperson said.
"We have written to UK CBD stockists and manufacturers to inform them of our view. We can provide regulatory guidance to any company who may wish to apply for a licence."
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments